FN1 and neoplasm: As observed for the orthotopic model (Fig. 1A), the “boost” in CAF-dependent tumor initiation at a subcutaneous site could be prevented using CAFs with siRNA-mediated knockdown of FN1, whereas CAFs with ITGA5 knockdown produced tumors at 1 of 11 injection sites.